|
 New research published in JAMA Internal Medicine is offering the best insight to date into the long-term benefit of a third COVID-19 vaccine dose. Tracking over 300,000 subjects in Israel the research shows a third dose of Pfizer's mRNA vaccine reduces a person's chance of SARS-CoV-2 infection by 86 percent compared to two doses.
Continue Reading
Health & Wellbeing, Lifestyle
Coronavirus (COVID-19), Vaccines, Israel, The Immune System
|
|
